Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FG3PL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,746
Award facts
- Contract value 100% obligated
- $12,746.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12.7K to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 21, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, representing the type of specialty pharmaceutical products that support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999.9M through December 2026. As a major pharmaceutical distributor serving federal medical procurement, AmerisourceBergen (parent company Cencora, Inc.) maintains a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally. The firm fixed-price structure and competitive award reflect the company's established capability to efficiently fulfill federal pharmaceutical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FG3PL?
SPE2DR26FG3PL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FG3PL worth?
The government has obligated $12,746 on SPE2DR26FG3PL.
Is contract SPE2DR26FG3PL an order under another contract?
Yes. SPE2DR26FG3PL is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3PL competed?
The extent of competition for SPE2DR26FG3PL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award